Treatment of myeloma: cure vs control
- PMID: 18828974
- PMCID: PMC3923461
- DOI: 10.4065/83.10.1142
Treatment of myeloma: cure vs control
Comment in
-
Is "cure" essential in the treatment of cancer?Mayo Clin Proc. 2008 Dec;83(12):1413-4. doi: 10.1016/S0025-6196(11)60795-7. Mayo Clin Proc. 2008. PMID: 19046548 No abstract available.
References
-
- Sirohi B, Powles R. International myeloma grand round. Lancet Oncol. 2001;2(9):571–579. - PubMed
-
- Mehta J, Singhal S. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years. Bone Marrow Transplant. 2007 Dec;40(12):1101–1114. Epub 2007 Aug 6. - PubMed
-
- Durie BGM, Harousseau J-L, Miguel JS, et al. International Myeloma Working Group. International uniform response criteria for multiple myeloma [published corrections appear in Leukemia 2006;20(12):2220 and 2007, 21 (5), 1134] Leukemia. 2006 Sep;20(9):1467–1473. Epub 2006 Jul 20. - PubMed
-
- Anderson KC, Kyle RA, Rajkumar SV, Stewart AK, Weber D, Richardson P. ASH/FDA Panel on Clinical Endpoints in Multiple Myeloma. Clinically relevant end points and new drug approvals for myeloma. Leukemia. 2008 Feb;22(2):231–239. Epub 2007 Nov 1. - PubMed
-
- Attal M, Harousseau JL, Stoppa AM, et al. Intergroupe Francais du Myelome. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335 (2):91–97. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
